Dihydroartemisinin alleviates morphine-induced neuroinflammation in BV-2 cells

References

• Gretton SK, Ross JR, Rutter D, et al. Plasma morphine and metabolite concentrations are associated with clinical effects of morphine in cancer patients. J Pain Symptom Manage. 2013;45(4):670–680.
   PubMed Web of Science ®Google Scholar
• Williams JT, Ingram SL, Henderson G, et al. Regulation of mu-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol Rev. 2013;65(1):223–254.
   PubMed Web of Science ®Google Scholar
• Corder G, Tawfik VL, Wang D, et al. Loss of mu opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia. Nat Med. 2017;23(2):164–173.
   PubMed Web of Science ®Google Scholar
• Eidson LN, Murphy AZ. Persistent peripheral inflammation attenuates morphine-induced periaqueductal gray glial cell activation and analgesic tolerance in the male rat. J Pain. 2013;14(4):393–404.
   PubMed Web of Science ®Google Scholar
• Ferrini F, Trang T, Mattioli TA, et al. Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl(-) homeostasis. Nat Neurosci. 2013;16(2):183–192.
   PubMed Web of Science ®Google Scholar
• Cai Y, Kong H, Pan YB, et al. Procyanidins alleviates morphine tolerance by inhibiting activation of NLRP3 inflammasome in microglia. J Neuroinflammation. 2016;13(1):53.
   PubMedGoogle Scholar
• Tu Y. Artemisinin-A gift from traditional Chinese medicine to the world (Nobel lecture). Angew Chem Int Ed Engl. 2016;55(35):10210–10226.
   PubMed Web of Science ®Google Scholar
• Huang X, Xie Z, Liu F, et al. Dihydroartemisinin inhibits activation of the Toll-like receptor 4 signaling pathway and production of type I interferon in spleen cells from lupus-prone MRL/lpr mice. Int Immunopharmacol. 2014;22(1):266–272.
   PubMed Web of Science ®Google Scholar
• Hui HY, Wu N, Wu M, et al. Dihydroartemisinin suppresses growth of squamous cell carcinoma A431 cells by targeting the Wnt/beta-catenin pathway. Anticancer Drugs. 2016;27(2):99–105.
   PubMed Web of Science ®Google Scholar
• Yi R, Wang H, Deng C, et al. Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition. Biosci Rep. 2020;40(6). DOI:10.1042/BSR20193314.
   Web of Science ®Google Scholar
• Li N, Sun W, Zhou X, et al. Dihydroartemisinin protects against Dextran Sulfate Sodium-Induced colitis in mice through inhibiting the PI3K/AKT and NF-kappaB signaling pathways. Biomed Res Int. 2019;2019:1415809.
   PubMedGoogle Scholar
• Yang DX, Qiu J, Zhou HH, et al. Dihydroartemisinin alleviates oxidative stress in bleomycin-induced pulmonary fibrosis. Life Sci. 2018;205:176–183.
   PubMed Web of Science ®Google Scholar
• Gao Y, Cui M, Zhong S, et al. Dihydroartemisinin ameliorates LPS-induced neuroinflammation by inhibiting the PI3K/AKT pathway. Metab Brain Dis. 2020;35(4):661–672.
   PubMed Web of Science ®Google Scholar
• Wang X, Loram LC, Ramos K, et al. Morphine activates neuroinflammation in a manner parallel to endotoxin. Proc Natl Acad Sci U S A. 2012;109(16):6325–6330.
   PubMed Web of Science ®Google Scholar
• Qu J, Tao XY, Teng P, et al. Blocking ATP-sensitive potassium channel alleviates morphine tolerance by inhibiting HSP70-TLR4-NLRP3-mediated neuroinflammation. J Neuroinflammation. 2017;14(1):228.
   PubMedGoogle Scholar
• Han Y, Jiang C, Tang J, et al. Resveratrol reduces morphine tolerance by inhibiting microglial activation via AMPK signalling. Eur J Pain. 2014;18(10):1458–1470.
   PubMed Web of Science ®Google Scholar
• Bai L, Zhai C, Han K, et al. Toll-like receptor 4-mediated nuclear factor-kappaB activation in spinal cord contributes to chronic morphine-induced analgesic tolerance and hyperalgesia in rats. Neurosci Bull. 2014;30(6):936–948.
   PubMed Web of Science ®Google Scholar
• Oeckinghaus A, Ghosh S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol. 2009;1(4):a000034.
   PubMed Web of Science ®Google Scholar
• Cao C, Yin C, Shou S, et al. Ulinastatin protects against LPS-Induced acute lung injury by attenuating TLR4/NF-kappaB pathway activation and reducing inflammatory mediators. Shock. 2018;50(5):595–605.
   PubMed Web of Science ®Google Scholar
• Ju M, Liu B, He H, et al. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting in fl ammation and apoptosis through modulating TLR4/MyD88/NF-kappaB pathway. Cell Cycle. 2018;17(16):2001–2018.
   PubMed Web of Science ®Google Scholar
• Shafie A, Moradi F, Izadpanah E, et al. Neuroprotection of donepezil against morphine-induced apoptosis is mediated through toll-like receptors. Eur J Pharmacol. 2015;764:292–297.
   PubMed Web of Science ®Google Scholar
• Hutchinson MR, Zhang Y, Shridhar M, et al. Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav Immun. 2010;24(1):83–95.
   PubMed Web of Science ®Google Scholar
• Wang S, Wang H, Lin C, et al. Structure-activity relationship study of dihydroartemisinin C-10 hemiacetal derivatives as toll-like receptor 4 antagonists. Bioorg Chem. 2021;114:105107.
   PubMed Web of Science ®Google Scholar
• Yang Y, Yang F, Yu X, et al. miR-16 inhibits NLRP3 inflammasome activation by directly targeting TLR4 in acute lung injury. Biomed Pharmacother. 2019;112:108664.
   PubMed Web of Science ®Google Scholar
• Liang X, Xu Z, Yuan M, et al. MicroRNA-16 suppresses the activation of inflammatory macrophages in atherosclerosis by targeting PDCD4. Int J Mol Med. 2016;37(4):967–975.
   PubMed Web of Science ®Google Scholar
• Talari M, Kapadia B, Kain V, et al. MicroRNA-16 modulates macrophage polarization leading to improved insulin sensitivity in myoblasts. Biochimie. 2015;119:16–26.
   PubMed Web of Science ®Google Scholar
• Sun H, Meng X, Han J, et al. Anti-cancer activity of DHA on gastric cancer–an in vitro and in vivo study. Tumour Biol. 2013;34(6):3791–3800.
   PubMedGoogle Scholar
• Li Y, Wang Y, Kong R, et al. Dihydroartemisinin suppresses pancreatic cancer cells via a microRNA-mRNA regulatory network. Oncotarget. 2016;7(38):62460–62473.
   PubMedGoogle Scholar
• Yang B, Gao X, Sun Y, et al. Dihydroartemisinin alleviates high glucose-induced vascular smooth muscle cells proliferation and inflammation by depressing the miR-376b-3p/KLF15 pathway. Biochem Biophys Res Commun. 2020;530(3):574–580.
   PubMed Web of Science ®Google Scholar
• Zhu H, Ji W. Dihydroartemisinin ameliorated ovalbumin-Induced asthma in mice via regulation of miR-183C. Med Sci Monit. 2019;25:3804–3814.
   PubMed Web of Science ®Google Scholar